Breaking News Instant updates and real-time market news.

SPWR

SunPower

$9.47

0.98 (11.54%)

, VSLR

Vivint Solar

$4.10

(0.00%)

09:22
01/12/18
01/12
09:22
01/12/18
09:22

President may announce solar tariff next week, says Roth Capital

Roth Capital analyst Philip Shen said his checks suggest President Trump may make a final 201 tariff announcement regarding the solar power industry next week. Shen continues to expect a 30%-50% 201 tariff, he noted. Solar industry stocks include SunPower (SPWR), Vivint Solar (VSLR), SolarEdge (SEDG), Enphase Energy (ENPH), First Solar (FSLR), Canadian Solar (CSIQ), JA Solar (JASO), JinkoSolar (JKS), Sunrun (RUN), Sky Solar (SKYS), ReneSola (SOL) and Yingli Green Energy (YGE).

SPWR

SunPower

$9.47

0.98 (11.54%)

VSLR

Vivint Solar

$4.10

(0.00%)

SEDG

SolarEdge

$37.50

0.9 (2.46%)

ENPH

Enphase Energy

$2.40

0.14 (6.19%)

FSLR

First Solar

$76.27

6.63 (9.52%)

CSIQ

Canadian Solar

$17.30

0.37 (2.19%)

JASO

JA Solar

$7.45

-0.07 (-0.93%)

JKS

JinkoSolar

$24.77

(0.00%)

RUN

Sunrun

$6.30

0.28 (4.65%)

SKYS

Sky Solar

$1.54

0.045 (3.02%)

SOL

ReneSola

$3.07

(0.00%)

YGE

Yingli Green Energy

$2.05

(0.00%)

  • 26

    Feb

SPWR SunPower
$9.47

0.98 (11.54%)

12/11/17
BARD
12/11/17
UPGRADE
Target $10
BARD
Outperform
SunPower upgraded to Outperform from Neutral at Baird
Baird analyst Ben Kallo upgraded SunPower (SPWR) to Outperform from Neutral, as he believes sentiment should improve over the next few quarters as the company sells 8point3 Energy (CAFD) and potentially other assets and ramps production of its P series modules. He raised his price target on SunPower shares to $10 from $7.
12/22/17
BOFA
12/22/17
INITIATION
Target $10
BOFA
Neutral
SunPower reinstated with a Neutral at BofA/Merrill
BofA/Merrill analyst Julien Dumoulin-Smith reinstated SunPower with a Neutral and $10 price target given modest free-cash-flow growth and longer-term threats from premium pricing and peers improving efficiency of panels.
11/02/17
RILY
11/02/17
NO CHANGE
RILY
Tax reform bill a 'mixed bag' for renewable energy, says B. Riley FBR
B. Riley FBR analyst Benjamin Salisbury called the House tax reform proposal a "mixed bag" for renewable energy credits, noting that it would end the tax credit for commercial-scale solar projects after 2027, reduce the available wind tax credit and extend the orphaned tax credits, including fuel cells. The plan is still being negotiated and Salisbury sees a 30-40% probability that Congress can pass a tax cut mirroring the recent GOP blueprint and a 55-65% chance they could pass a scaled-down version. Publicly traded companies in the solar space include Canadian Solar (CSIQ), First Solar (FSLR), JA Solar (JASO), SunPower (SPWR), Trina Solar (TSL) and Yingli Green Energy (YGE). The Fly notes that Plug Power (PLUG) has issued a statement applauding the Committee for "addressing the market disparity that was created in 2015."
12/11/17
BARD
12/11/17
UPGRADE
BARD
Outperform
SunPower upgraded to Outperform from Neutral at Baird
VSLR Vivint Solar
$4.10

(0.00%)

11/06/17
BOFA
11/06/17
INITIATION
Target $5
BOFA
Buy
Vivint Solar reinstated with a Buy at BofA/Merrill
BofA/Merrill analyst Julien Dumoulin-Smith reinstated Vivint Solar with a Buy and $5 price target saying sector risks are overblown and solar renewable energy credits are a value contributor
08/09/17
DBAB
08/09/17
DOWNGRADE
Target $5.5
DBAB
Hold
Vivint Solar downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Vishal Shah downgraded Vivint Solar to Hold citing limited near term catalysts and his belief the current valuation adequately reflects some of the company's financial turnaround. The analyst lowered his price target for the shares to $5.50 from $6 following Vivint's Q2 results.
09/27/17
GUGG
09/27/17
INITIATION
Target $5
GUGG
Buy
Vivint Solar initiated with a Buy at Guggenheim
Guggenheim analyst Sophie Karp initiated Vivent with a Buy and a $5 price target.
11/01/17
OPCO
11/01/17
NO CHANGE
OPCO
Investment tax credit reduction becoming material risk to solar companies, says Oppenheimer
As solar investors digest reports that the International Trade Commission is proposing up to a 30%-35% import tariff for crystalline solar panels imported into the U.S. related to the Section 201 filing, Oppenheimer analyst Colin Rusch believes a bigger policy story is brewing. The analyst notes that the investment tax credit for solar has entered the mix as an area of potential savings, and believes an investment tax credit reduction is becoming a material risk to solar companies, in particular Sunrun (RUN), Vivint Solar (VSLR), First Solar (FSLR), and Enphase Energy (ENPH) and to a lesser extent SolarEdge (SEDG) and SunPower (SPWR).
SEDG SolarEdge
$37.50

0.9 (2.46%)

11/09/17
JPMS
11/09/17
NO CHANGE
Target $43
JPMS
Overweight
SolarEdge price target raised to $43 from $37 at JPMorgan
JPMorgan analyst Mark Strouse raised his price target for SolarEdge Technologies to $43 saying the company reported "another beat and raise" for Q3. The analyst believes the stock's risk/reward remains favorable and that continued execution could drive further upside to estimates. He keeps an Overweight rating on SolarEdge.
12/06/17
ROTH
12/06/17
NO CHANGE
ROTH
Tax bill could put 'BEAT' down on U.S. renewables, says Roth Capital
Roth Capital analyst Philip Shen believes the Senate Tax Cuts and Jobs Act includes multiple elements that could negatively affect renewable tax equity capacity, such as a cut in the corporate rate from 35% to 20%, the passage of the Base Erosion Anti-Abuse Tax, or BEAT, without exemptions for solar/wind credits, and a reduction in the number of years the product tax credit could be claimed from 10 down to four years. Near-term, the analyst believes that continued negotiations on the Hill could cause increased volatility for his universe of stocks with direct or indirect exposure to the U.S. solar and wind markets, such as AMSC (AMSC), Broadwind Energy (BWEN), 8point3 Energy (CAFD), Canadian Solar (CSIQ), Daqo New Energy (DQ), Enphase Energy (ENPH), First Solar (FSLR), Hannon Armstrong (HASI), Hanwah Q CELLS (HQCL), JA Solar (JASO), JinkoSolar (JKS), SolarEdge (SEDG), Sky Solar (SKYS), ReneSola (SOL), Sunworks (SUNW), and TPI Composites (TPIC).
01/11/18
VERF
01/11/18
INITIATION
VERF
Sell
SolarEdge initiated with a Sell at Vertical Group
Vertical Group analyst Gordon Johnson started SolarEdge with a Sell rating saying his analysis suggests the shares are "considerably" overvalued. Johnson believes SolarEdge gross margins may peak in 2018 and that its EBITDA may have already peaked.
11/27/17
DBAB
11/27/17
DOWNGRADE
Target $40
DBAB
Hold
SolarEdge downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Vishal Shah downgraded SolarEdge to Hold saying the shares at current levels are fully discounting prospects of strong execution in solar and non-solar segments. The analyst believes 2018 industry volumes could disappoint to the downside and feels noise around increased competition from Huawei will likely increase over the next few quarters. Shah sees limited upside to 2018 consensus estimates and keeps a $40 price target for SolarEdge shares.
ENPH Enphase Energy
$2.40

0.14 (6.19%)

06/20/17
DBAB
06/20/17
UPGRADE
Target $1
DBAB
Hold
Enphase Energy upgraded to Hold from Sell at Deutsche Bank
Deutsche Bank analyst Vishal Shah upgraded Enphase Energy to Hold with an unchanged price target of $1. The analyst believes the company is taking steps in the right direction and can improve competitiveness and margins in the near to medium term.
06/12/17
CHLM
06/12/17
INITIATION
Target $2
CHLM
Buy
Enphase Energy resumed with a Buy at Craig-Hallum
Craig-Hallum analyst Eric Stine resumed coverage of Enphase Energy with a Buy rating and $2 price target. The company's microinverter business alone supports the stock at current levels while any contribution from energy storage could result in "substantial share upside," Stine tells investors in a research note. He expects the company to report quarter-over-quarter improvement in its Q2 results.
FSLR First Solar
$76.27

6.63 (9.52%)

01/11/18
VERF
01/11/18
INITIATION
VERF
Buy
First Solar initiated with a Buy at Vertical Group
Vertical Group analyst Gordon Johnson started First Solar with a Buy rating saying his analysis suggests the shares are "decidedly" undervalued. The analyst sees the stock "significantly" outperforming peers over the next 12 months.
12/21/17
ROTH
12/21/17
NO CHANGE
Target $80
ROTH
Buy
More upside, positive sentiment ahead for First Solar, says Roth Capital
Roth Capital analyst Philip Shen notes that bookings momentum continues for First Solar as the company announced earlier a 100MW module order with Zorlu Energi bringing the company's announced bookings to 7.8GW. The analyst believes First Solar has line of sight to reach 10.5GW of bookings near-term versus the company's 2018-2020 production of 14GW. As Section 201 unfolds, Shen sees potential upside to earnings in a high tariff scenario, while he believes First Solar's order book insulates earnings from a low/no tariff scenario. The analyst reiterates a Buy rating and $80 price target on the shares.
12/18/17
JPMS
12/18/17
NO CHANGE
Target $69
JPMS
Neutral
First Solar price target raised to $69 from $59 at JPMorgan
JPMorgan analyst Paul Coster raised his price target for First Solar to $69 saying his prior estimates for gross margins, once Series 6 production is fully ramped, may have been too conservative. The analyst upped his estimates for fiscal 2019 but keeps a Neutral rating on First Solar. He feels the stock is fully valued at current levels and prefers to wait for a better entry point.
01/11/18
01/11/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Netflix (NFLX) initiated with an Overweight at Barclays. 2. Dollar Tree (DLTR) initiated with a Buy at Guggenheim. 3. Coupa Software (COUP) initiated with a Buy at Needham. 4. First Solar (FSLR) initiated with a Buy at Vertical Group. 5. Bellatrix Exploration (BXE) initiated with an Underperform at BMO Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
CSIQ Canadian Solar
$17.30

0.37 (2.19%)

12/12/17
JPMS
12/12/17
DOWNGRADE
Target $15
JPMS
Underweight
Canadian Solar downgraded to Underweight with $15 target at JPMorgan
JPMorgan analyst Paul Coster downgraded Canadian Solar to Underweight from Neutral with an unchanged price target of $15. The stock is likely capped by the CEO's take-private offer of $18.47, Coster tells investors in a research note. The analyst expects the stock to underperform his coverage in the near-term, but says it is not a short. He believes, however, that a higher, competing takeover offer is likely.
12/12/17
JPMS
12/12/17
DOWNGRADE
JPMS
Underweight
Canadian Solar downgraded to Underweight from Neutral at JPMorgan
01/09/18
GSCO
01/09/18
INITIATION
Target $19
GSCO
Neutral
Canadian Solar initiated with a Neutral at Goldman Sachs
Goldman Sachs analyst Brian Lee started Canadian Solar with a Neutral rating and $19 price target. The analyst sees limiteds upside potential with the company's project visibility "beginning to wane."
12/15/17
AXIO
12/15/17
DOWNGRADE
Target $17
AXIO
Hold
Canadian Solar downgraded to Hold from Buy at Axiom
Axiom analyst Gordon Johnson downgraded Canadian Solar to Hold with a $17 price target. The analyst believes a better takeover offer than the $18.47 per share from management is unlikely. Johnson sees fundamental headwinds for the company.
JASO JA Solar
$7.45

-0.07 (-0.93%)

08/29/17
08/29/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. JA Solar (JASO) downgraded to Sell from Hold at Axiom with analyst Gordon Johnson saying recent results suggest that Chinese module vendors are not benefiting significantly from any U.S. demand pull-in. 2. Finish Line (FINL) was downgraded to Sell from Neutral at Citi and Deutsche Bank, while being downgraded to Underperform from Neutral at Buckingham, and to Neutral from Buy at FBR Capital. 3. Intellia Therapeutics (NTLA) downgraded to Neutral from Buy at Chardan with analyst Madhu Kumar citing relative valuation. 4. Loxo Oncology (LOXO) downgraded to Market Perform from Outperform at JMP Securities with analyst Michael King saying he believes the company's platform and assets under development are now being fairly valued with the stock having risen above his $71 price target. 5. Cemex (CX) downgraded to Neutral from Buy at BofA/Merrill with analyst Carlos Peyrelongue citing lack of positive catalysts and risk of disappointment in Mexico and the U.S. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/16/17
AXIO
11/16/17
NO CHANGE
AXIO
Sell
JA Solar 'may be on borrowed time' given troubling cash burn, says Axiom
Axiom analyst Gordon L. Johnson II said JA Solar's cash burn could mean trouble, estimating the company will run out of money at some point in the first or second quarter of next year at the current rate. The analyst contends the company "may be on borrowed time," assuming it is not acquired or taken private. Johnson II keeps a Sell rating on JA Solar shares.
JKS JinkoSolar
$24.77

(0.00%)

09/21/17
09/21/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Netflix (NFLX) initiated with a Buy at Buckingham. 2. Paycom (PAYC) initiated with an Outperform at Northland. 3. JinkoSolar (JKS) initiated with a Sell at Axiom. 4. Ares Capital (ARCC) initiated with an Outperform at Oppenheimer. 5. Versum Materials (VSM) initiated with a Hold at Stifel. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
01/09/18
GSCO
01/09/18
INITIATION
Target $16
GSCO
Sell
JinkoSolar initiated with a Sell at Goldman Sachs
Goldman Sachs analyst Brian Lee started JinkoSolar with a Sell rating and $16 price target. The analyst expects further margin compression for the solar supply chain in early 2018 due to higher raw materials costs and seasonally weaker module pricing. He believes JinkoSolar is in an unfavorable position given its pure play exposure to the component supply chain.
09/25/17
ROTH
09/25/17
NO CHANGE
Target $26
ROTH
Neutral
JinkoSolar price target raised to $26 from $18 at Roth Capital
Roth Capital analyst Philip Shen raised his price target for JinkoSolar to $26 from $18 after the section 201 injury vote. However, the analyst notes that the U.S. represents a modest 10%-15% of the company's overall shipments. He reiterates a Neutral rating on the shares.
RUN Sunrun
$6.30

0.28 (4.65%)

11/06/17
BOFA
11/06/17
INITIATION
Target $8
BOFA
Buy
Sunrun reinstated with a Buy at BofA/Merrill
BofA/Merrill analyst Julien Dumoulin-Smith reinstated Sunrun with a Buy and $8 price target saying he is confident in management's ability to deliver on its overall strategy.
06/20/17
GSCO
06/20/17
UPGRADE
Target $6
GSCO
Buy
Vivint Solar upgraded to Buy from Neutral at Goldman Sachs
Goldman Sachs analyst Brian Lee upgraded Vivint Solar to Buy citing the potential for increased mergers and acquisitions in the U.S. solar sector. The analyst raised his price target for the shares to $6 from $3.50. Lee assigned Vivint Goldman's highest M&A rank of 1 and sees increased restructuring potential in the residential solar business. The analyst also raised his price targets for Buy-rated Sunrun (SUN) to $10 and Buy-rated 8point3 Energy (CAFD) to $16.
07/25/17
BOFA
07/25/17
NO CHANGE
BOFA
Solar sector may be bottoming, First Solar best positioned, says BofA/Merrill
BofA/Merrill analyst Krish Sankar believes the Solar sector may have bottomed in Q2 2017 with installs falling about 23% compared to Q2 2016 as last year's rush was driven by fears of an ITC expiration. Sankar believes global demand is set to increase 2% in 2017, followed by mid-to-high single digit growth going forward. His top solar pick heading into earnings is First Solar (FSLR), followed by Buy rated Veeco (VECO) in the energy efficiency/LED space. The analyst remains sidelined, until there is clarity on future sponsors, in SunPower (SPWR) and 8Point3 (CAFD).
SKYS Sky Solar
$1.54

0.045 (3.02%)

10/11/17
ROTH
10/11/17
UPGRADE
ROTH
Buy
Sky Solar upgraded to Buy from Neutral at Roth Capital
10/11/17
10/11/17
UPGRADE
Target $5

Buy
Sky Solar upgraded to Buy at Roth Capital
As previously reported, Roth Capital analyst Philip Shen upgraded Sky Solar to Buy from Neutral as his updated liquidation analysis suggests the value of the company's portfolio and pipeline is about $5/share. The analyst also raised his price target on the shares to $5 from $1.30.
06/16/17
ROTH
06/16/17
DOWNGRADE
Target $1.3
ROTH
Neutral
Sky Solar downgraded to Neutral on CEO removal at Roth Capital
Roth Capital analyst Philip Shen downgraded Sky Solar to Neutral from Buy and cut his price target for the shares to $1.30 from $8. The analyst sees the stock trading "sideways to down" given the recent removal of CEO Weili Su and the ongoing investigation into his conduct. The analyst now questions the potential impact to the economic value of the company.
SOL ReneSola
$3.07

(0.00%)

10/16/17
10/16/17
UPGRADE
Target $2.55

Neutral
ReneSola upgraded to Neutral at Roth Capital
As previously reported, Roth Capital analyst Justin Clare upgraded ReneSola to Neutral from Sell and raised his price target on the shares to $2.55 from $2.05 on the improved outlook for the business and potential for greater earnings power ahead.
10/16/17
ROTH
10/16/17
UPGRADE
ROTH
Neutral
ReneSola upgraded to Neutral from Sell at Roth Capital
04/18/17
OTRG
04/18/17
NO CHANGE
OTRG
Solar PV Manufacturers downgraded to Negative from Mixed at OTR Global
OTR Global view on crystalline PV producers in the solar integrator market was downgraded to Negative from Mixed following checks that indicate global crystalline PV prices fell in Q1 and inventories increased. Further 2017 Chinese installations are expected at 27-28GW, below 34.21 GW in 2016.
YGE Yingli Green Energy
$2.05

(0.00%)

08/24/17
AXIO
08/24/17
NO CHANGE
AXIO
JA Solar likely to report Q3 loss, says Axiom
Axiom analyst Gordon L Johnson III says his recent checks indicate that China and global prices for modules and cell dropped slightly last week, while spot prices for polysilicon and multi wafers used to make solar modules and cells rose sharply from July 12 to August 9 and have since been stable. As a result, the analyst calculates that companies which bought the raw materials at spot prices have seen their margins on solar cells fall to a record low -12.9%, while module makers who bought the raw materials at spot prices have margins of -3.7%, the lowest level since Axiom began tracking them. Given these trends, Johnson predicts that JA Solar will report a Q3 pretax loss of $10M and warns that the company's results could deteriorate further in Q4. Other publicly traded companies in the space include Canadian Solar (CSIQ), First Solar (FSLR), SunEdison (SUNEQ), SunPower (SPWR), Trina Solar (TSL) and Yingli Green Energy (YGE).

TODAY'S FREE FLY STORIES

ZTCOY

ZTE Corp.

$0.00

(0.00%)

05:58
05/22/18
05/22
05:58
05/22/18
05:58
Periodicals
U.S., China reach broad outline on deal to settle ZTE controversy, WSJ reports »

The U.S. and China have…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

HURN

Huron

$38.30

0.65 (1.73%)

05:57
05/22/18
05/22
05:57
05/22/18
05:57
Conference/Events
Huron management to meet with William Blair »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 12

    Jun

TOL

Toll Brothers

$43.60

0.43 (1.00%)

05:57
05/22/18
05/22
05:57
05/22/18
05:57
Earnings
Toll Brothers reports Q2 EPS 72c, consensus 76c »

Reports Q2 revenue $1.6B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

WWE

WWE

$57.86

6.37 (12.37%)

05:56
05/22/18
05/22
05:56
05/22/18
05:56
Conference/Events
WWE management to meet with MKM Partners »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

WD

Walker & Dunlop

$56.10

1.07 (1.94%)

05:55
05/22/18
05/22
05:55
05/22/18
05:55
Conference/Events
Walker & Dunlop management to meet with JMP Securities »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 24

    May

  • 31

    May

BUD

AB InBev

05:55
05/22/18
05/22
05:55
05/22/18
05:55
Upgrade
AB InBev rating change  »

AB InBev upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MMM

3M

$201.75

2.8 (1.41%)

, BAYRY

Bayer

$0.00

(0.00%)

05:55
05/22/18
05/22
05:55
05/22/18
05:55
Conference/Events
American Thoracic Society to hold a conference »

ATS 2018 will be held in…

MMM

3M

$201.75

2.8 (1.41%)

BAYRY

Bayer

$0.00

(0.00%)

BDX

Becton Dickinson

$228.74

3.73 (1.66%)

BIIB

Biogen

$277.69

-2.66 (-0.95%)

STEM

Ticker changed to MBOT

$0.00

(0.00%)

TEVA

Teva

$21.09

-0.14 (-0.66%)

UTHR

United Therapeutics

$104.12

-2.2 (-2.07%)

VCYT

Veracyte

$6.45

(0.00%)

VRTX

Vertex

$156.15

-1.09 (-0.69%)

NBRV

Nabriva Therapeutics

$4.54

-0.89 (-16.39%)

GILD

Gilead

$67.63

-0.38 (-0.56%)

GSK

GlaxoSmithKline

$40.05

0.005 (0.01%)

HRC

Hill-Rom

$90.70

0.12 (0.13%)

INNV

Innovus Pharmaceuticals

$0.00

(0.00%)

DNA

Bought by RHHBY

$0.00

(0.00%)

CELG

Celgene

$74.69

-3.7 (-4.72%)

JAZZ

Jazz Pharmaceuticals

$166.01

-1.59 (-0.95%)

ISRG

Intuitive Surgical

$463.18

4.3 (0.94%)

INSM

Insmed

$26.34

-2.16 (-7.58%)

REGN

Regeneron

$296.58

-5.29 (-1.75%)

OCX

OncoCyte

$2.50

-0.05 (-1.96%)

FGEN

FibroGen

$52.55

1.45 (2.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 24

    May

  • 30

    May

  • 30

    May

  • 31

    May

  • 03

    Jun

  • 05

    Jun

  • 05

    Jun

  • 12

    Jun

  • 13

    Jun

  • 13

    Jun

  • 14

    Jun

  • 16

    Jun

  • 25

    Jun

  • 26

    Jun

  • 11

    Aug

  • 20

    Oct

  • 20

    Dec

CCJ

Cameco

$11.38

0.015 (0.13%)

05:54
05/22/18
05/22
05:54
05/22/18
05:54
Downgrade
Cameco rating change  »

Cameco downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TER

Teradyne

$38.17

0.77 (2.06%)

05:54
05/22/18
05/22
05:54
05/22/18
05:54
Conference/Events
Teradyne management to meet with Craig Hallum »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 30

    May

RTN

Raytheon

$213.95

2.88 (1.36%)

05:54
05/22/18
05/22
05:54
05/22/18
05:54
Downgrade
Raytheon rating change  »

Raytheon downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYRS

Syros Pharmaceuticals

$11.96

-0.41 (-3.31%)

05:54
05/22/18
05/22
05:54
05/22/18
05:54
Conference/Events
Syros Pharmaceuticals management to meet with JMP Securities »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

SPSC

SPS Commerce

$71.88

0.11 (0.15%)

05:53
05/22/18
05/22
05:53
05/22/18
05:53
Conference/Events
SPS Commerce management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 24

    May

  • 29

    May

  • 12

    Jun

RDCM

Radcom

$19.65

0.25 (1.29%)

05:52
05/22/18
05/22
05:52
05/22/18
05:52
Conference/Events
Radcom management to meet with Needham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 24

    May

  • 24

    May

  • 29

    May

INFO

IHS Markit

$51.60

0.13 (0.25%)

05:52
05/22/18
05/22
05:52
05/22/18
05:52
Upgrade
IHS Markit rating change  »

IHS Markit upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FITB

Fifth Third

$30.89

-2.66 (-7.93%)

05:51
05/22/18
05/22
05:51
05/22/18
05:51
Upgrade
Fifth Third rating change  »

Fifth Third upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QTM

Quantum

$3.62

-0.06 (-1.63%)

05:51
05/22/18
05/22
05:51
05/22/18
05:51
Conference/Events
Quantum management to meet with Lake Street »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 29

    May

FITB

Fifth Third

$30.89

-2.66 (-7.93%)

05:51
05/22/18
05/22
05:51
05/22/18
05:51
Upgrade
Fifth Third rating change  »

Fifth Third upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OTEX

OpenText

$34.10

0.1 (0.29%)

05:51
05/22/18
05/22
05:51
05/22/18
05:51
Conference/Events
OpenText management to meet with Benchmark »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

NVEE

NV5 Global

$60.60

0.6 (1.00%)

05:50
05/22/18
05/22
05:50
05/22/18
05:50
Conference/Events
NV5 Global management to meet with Lake Street »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 23

    May

  • 09

    Jun

  • 12

    Jun

  • 13

    Jun

M

Macy's

$34.60

0.63 (1.85%)

05:49
05/22/18
05/22
05:49
05/22/18
05:49
Upgrade
Macy's rating change  »

Macy's upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NCR

NCR Corp.

$31.30

0.11 (0.35%)

05:49
05/22/18
05/22
05:49
05/22/18
05:49
Conference/Events
NCR Corp. management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 23

    May

ONCE

Spark Therapeutics

$73.03

-3.69 (-4.81%)

, PFE

Pfizer

$35.79

0.15 (0.42%)

05:44
05/22/18
05/22
05:44
05/22/18
05:44
Hot Stocks
Spark Therapeutics, Pfizer announce data SPK-9001 ongoing Phase 1/2 trial »

Spark Therapeutics (ONCE)…

ONCE

Spark Therapeutics

$73.03

-3.69 (-4.81%)

PFE

Pfizer

$35.79

0.15 (0.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

  • 10

    Sep

FMC

FMC Corporation

$91.30

-0.22 (-0.24%)

05:41
05/22/18
05/22
05:41
05/22/18
05:41
Hot Stocks
FMC Corporation awarded contract for two fertilizer plants in India »

TechnipFMC, in consortium…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

S

Sprint

$5.17

0.05 (0.98%)

05:40
05/22/18
05/22
05:40
05/22/18
05:40
Hot Stocks
Sprint partners with Scopeworker on multi-billion dollar 5G depoloyment »

Scopeworker announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GSHD

Goosehead Insurance

$16.19

0.12 (0.75%)

05:39
05/22/18
05/22
05:39
05/22/18
05:39
Initiation
Goosehead Insurance initiated  »

Goosehead Insurance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.